NeoImmuneTech Statistics

Total Valuation

NeoImmuneTech has a market cap or net worth of KRW 20.35 billion. The enterprise value is 20.32 billion.

Market Cap	20.35B
Enterprise Value	20.32B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

NeoImmuneTech has 19.77 million shares outstanding. The number of shares has decreased by -0.22% in one year.

Current Share Class	n/a
Shares Outstanding	19.77M
Shares Change (YoY)	-0.22%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.78%
Owned by Institutions (%)	4.79%
Float	14.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	578.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-497.12
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-464.33

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.26.

Current Ratio	1.89
Quick Ratio	1.68
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-0.25
Interest Coverage	-56.44

Financial Efficiency

Return on equity (ROE) is -70.17% and return on invested capital (ROIC) is -39.04%.

Return on Equity (ROE)	-70.17%
Return on Assets (ROA)	-32.84%
Return on Invested Capital (ROIC)	-39.04%
Return on Capital Employed (ROCE)	-91.78%
Revenue Per Employee	2,073
Profits Per Employee	-498,549
Employee Count	82
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.95% in the last 52 weeks. The beta is 0.81, so NeoImmuneTech's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-38.95%
50-Day Moving Average	1,116.32
200-Day Moving Average	1,333.57
Relative Strength Index (RSI)	37.37
Average Volume (20 Days)	277,885

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NeoImmuneTech had revenue of KRW 170,000 and -40.88 million in losses. Loss per share was -414.60.

Revenue	170,000
Gross Profit	170,000
Operating Income	-40.97M
Pretax Income	-40.87M
Net Income	-40.88M
EBITDA	-37.02M
EBIT	-40.97M
Loss Per Share	-414.60

Full Income Statement

Balance Sheet

The company has 34.84 million in cash and 10.77 million in debt, giving a net cash position of 24.06 million or 1.22 per share.

Cash & Cash Equivalents	34.84M
Total Debt	10.77M
Net Cash	24.06M
Net Cash Per Share	1.22
Equity (Book Value)	41.66M
Book Value Per Share	n/a
Working Capital	18.55M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -42.10 million and capital expenditures -1.67 million, giving a free cash flow of -43.77 million.

Operating Cash Flow	-42.10M
Capital Expenditures	-1.67M
Free Cash Flow	-43.77M
FCF Per Share	-2.21

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-24,101.76%
Pretax Margin	-24,040.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NeoImmuneTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.22%
Shareholder Yield	0.22%
Earnings Yield	-0.20%
FCF Yield	-0.22%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a